Please login to the form below

Not currently logged in
Email:
Password:

AZ said to be eyeing Forest takeover bid

Financial Times says pharma companies are in early negotiations

AstraZeneca (AZ) is considering a takeover bid for Forest Laboratories of the US, according to a Financial Times report which cites people close to two companies.

The rumour comes shortly after recently appointed Forest chief executive Brenton Saunders announced a major shake-up of the company's operations, including a cost-cutting programme aimed at trimming $500m off its cost base and a $400m share buyback.

The FT suggests AZ financial advisers recently met the senior management at Forest to discuss a cash offer for the company, which is valued at around $15bn, but that the negotiations are still in very preliminary stages.

At that valuation, any bid for Forest could rival the $15.6bn AZ paid for Medimmune five years ago to boost its biologics pipeline, a deal which some have suggested was priced too high.

One of the draws for AZ is that Forest's product pipeline is pretty closely aligned with its own R&D priorities, with a particular focus on treatments for central nervous system (CNS) disorders as well as cardiovascular and respiratory medicine and infectious diseases.

After several pipeline setbacks, AZ has signed a string of acquisition and licensing deals under CEO Pascal Soriot, who took over the reins of the pharma giant last year with a pledge to streamline and reform the business.

Last month the company agreed to pay $440m to buy antibody-drug conjugate (ADC) specialist Spirogen, while in August it bought cancer company Amplimmune in a deal valued at up to $500m. Earlier this year it bought respiratory company Pearl Therapeutics in a $1.15bn deal as well as US biotechs AlphaCore Pharma and Omthera Pharmaceuticals.

Analysts suggested that the timing of Forest's restructuring drive - in particular with share buyback - may be a defensive measure to make sure it secures a premium price in any buy-out of the business.

Article by
Phil Taylor

4th December 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics